Additionally, the court ruled that Exelixis' pharmaceutical composition patent (U.S. 11,298,349) is not invalid and not infringed by MSN's proposed ANDA product. "We are pleased with the court's ...

Exelixis (EXEL – Research Report), the Healthcare sector company, was revisited by a Wall Street analyst today. Analyst Stephen Willey ...

Leerink Partners analyst Andrew Berens has maintained their neutral stance on EXEL stock, giving a Hold rating today. Andrew Berens has given ...

ALAMEDA, Calif.--(BUSINESS WIRE)--Exelixis, Inc. (Nasdaq: EXEL) today announced that in the lawsuit Exelixis, Inc. (Exelixis) vs. MSN Laboratories Private Limited et al. (MSN), Civil Action No.

We will look at 20 famous fonts in logos – and figure out what makes them work, what they say, and how they’ve influenced most famous brands. Have you ever noticed how some brands just stay with you?

This fun logo quiz features five challenging rounds, and includes themed rounds on car logos, food companies and fashion brands. If there’s one thing lockdown taught us, it was that quizzes were a ...

ALAMEDA, Calif.--(BUSINESS WIRE)-- Exelixis, Inc. (Nasdaq: EXEL) today announced that in the lawsuit Exelixis, Inc. (Exelixis) vs. MSN Laboratories Private Limited et al. (MSN), Civil Action No.

Probably best known for the cancer drug Cabometyx (cabozantinib), which is marketed by Ipsen outside of the US and Japan, Exelixis already has four small-molecule drugs on the market. But CEO ...